Home - Products - Others - Other Targets - Cholecystokinin Octapeptide (1-6) (desulfated)

Cholecystokinin Octapeptide (1-6) (desulfated)

CAS No. 198483-36-2

Cholecystokinin Octapeptide (1-6) (desulfated)( ——— )

Catalog No. M41024 CAS No. 198483-36-2

Cholecystokinin Octapeptide (1-6) (desulfated)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cholecystokinin Octapeptide (1-6) (desulfated)
  • Note
    Research use only, not for human use.
  • Brief Description
    Cholecystokinin Octapeptide (1-6) (desulfated)
  • Description
    Cholecystokinin Octapeptide (1-6) (desulfated)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    198483-36-2
  • Formula Weight
    801.94
  • Molecular Formula
    C36H47N7O10S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lateritin

    Lateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.

  • cemadotin free base

    Cemadotin free base(LU103793 free base) is a novel anti-limiting peptide , an analog of Dolastatin 15, a naturally occurring cytotoxic peptide that blocks mitosis and inhibits microtubules (tubulin) with a Ki of 1 μM. Cemadotin is used in research against cancer.

  • Albiglutide TFA (782...

    Albiglutide TFA, a glucagon-like peptide (GLP)-1 mimetic, is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).